• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Semble: Venture Capital Funding History

Semble

To add a bio or update company history, please click update information.

News from Semble

    Semble secures £30m Series C led by Revaia to expand its healthcare coordination platform for outpatient providersSemble secures £30m Series C led by Revaia to expand its healthcare coordination platform for outpatient providers
    Semble
    4 Jun 2026

    Semble secures £30m Series C led by Revaia to expand its healthcare coordination platform for outpatient providers

    Semble is a healthcare management platform for outpatient providers that connects and coordinates every stage of the patient journey. The platform integrates with over 1,200 external tools across diagnostics, billing, labs and CRM, serving solo clinicians, group practices and enterprise healthcare organisations.

    Semble closes £11.5m Series B round for "connected healthcare" systemSemble closes £11.5m Series B round for "connected healthcare" system
    Semble
    29 Oct 2024

    Semble closes £11.5m Series B round for "connected healthcare" system

    Semble provides an integrated clinical system that automates healthcare administration and connects with third-party services, helping providers reduce paperwork and focus more on patient care.

Semble
  • Health
  • London, United Kingdom
  • £30m
  • semble.io
  • Update Information

More venture news

  • Inovus Medical lands £7m extension led by PXN Group to provide surgeons with surgical simulation training
    Inovus Medical
    30 Sept 2026

    Inovus Medical lands £7m extension led by PXN Group to provide surgeons with surgical simulation training

    EquityHealth
  • DYAD secures a £7.5m Series A led by Sangha Capital for its system that converts clinical documents into structured data for GP patient records
    DYAD
    29 Sept 2026

    DYAD secures a £7.5m Series A led by Sangha Capital for its system that converts clinical documents into structured data for GP patient records

    Series AHealth
  • IMS Solutions raises a £1.1m seed round led by Midlands Mindforge to develop steroid tests for cancer and PMOS
    IMS Solutions
    24 Sept 2026

    IMS Solutions raises a £1.1m seed round led by Midlands Mindforge to develop steroid tests for cancer and PMOS

    SeedHealth

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn